Live Breaking News & Updates on Alkermes Pharma Ireland Limited

Stay updated with breaking news from Alkermes pharma ireland limited. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Alkermes plc Reports First Quarter 2021 Financial Results

/PRNewswire/ Alkermes plc (Nasdaq: ALKS) today reported financial results for the first quarter of 2021. "Our first quarter results reflect solid execution. ....

United States , Katie Joyce , Iain Brown , Sandy Coombs , Schizophrenia International Research Society , Drug Administration , Biogen Inc , Merck Sharp Dohme Corp , Merck Co Inc , Exchange Commission , Alkermes Inc , Alkermes Pharma Ireland , Chief Financial Officer , Ended March , Goods Manufactured , Investor Day , Richard Pops , Chief Executive Officer , Value Enhancement Plan , Private Securities Litigation Reform Act , Annual Report , Alkermes Pharma Ireland Limited , Merck Sharp , Dohme Corp , Financial Information , Consolidated Statements ,

Baudax Bio Announces Publication of Phase IIIb Data on Preoperative Administration of ANJESO® in Patients Undergoing Total Knee Arthroplasty (TKA) in Pain Medicine

Baudax Bio Announces Publication of Phase IIIb Data on Preoperative Administration of ANJESO® in Patients Undergoing Total Knee Arthroplasty (TKA) in Pain Medicine
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Partnersdavid Rosen , Baudax Bio , Stewart Mccallum , Richard Berkowitz , Partnerssam Martin Claudia Styslinger , Ssris Snris , Perioperative Quality Initiative , Alkermes Pharma Ireland Limited , Baudax Bio Inc , Group Compared To Placebo , Exchange Commission , Replacement Center , Safety Results Following Administration Of Preoperative , American Society For Enhanced Recovery , University Orthopedic , Significantly Lower Summed Pain Intensity Scores , First Postsurgical Day , Throughout Their Inpatient , Mean Hospital Charges , Hospital Stay , Total Overall Charges Were Lower , American Society , Enhanced Recovery , Joint Replacement Center , Pain Medicine ,

Baudax Bio Announces Publication of Phase IIIb Data on Preoperative Administration of ANJESO® in Patients Undergoing Total Knee Arthroplasty (TKA) in Pain Medicine

Baudax Bio Announces Publication of Phase IIIb Data on Preoperative Administration of ANJESO® in Patients Undergoing Total Knee Arthroplasty (TKA) in Pain Medicine
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , David Rosen , Baudax Bio , Sam Martin Claudia Styslinger , Stewart Mccallum , Richard Berkowitz , Ssris Snris , Perioperative Quality Initiative , Alkermes Pharma Ireland Limited , Baudax Bio Inc , Group Compared To Placebo , Exchange Commission , Replacement Center , Safety Results Following Administration Of Preoperative , American Society For Enhanced Recovery , University Orthopedic , Significantly Lower Summed Pain Intensity Scores , First Postsurgical Day , Throughout Their Inpatient , Mean Hospital Charges , Hospital Stay , Total Overall Charges Were Lower , American Society , Enhanced Recovery , Joint Replacement Center , Pain Medicine ,

Alkermes Presents New Data From Psychiatry Portfolio at Virtual 2021 Congress of the Schizophrenia International Research Society

Alkermes Presents New Data From Psychiatry Portfolio at Virtual 2021 Congress of the Schizophrenia International Research Society
- New Exploratory Analyses Presented From ENLIGHTEN-2 Study of LYBALVI™ in Patients With Schizophrenia -
News provided by
Share this article
Share this article
DUBLIN, April 20, 2021 /PRNewswire/ Alkermes plc (Nasdaq: ALKS) today announced the presentation of new research from its psychiatry portfolio at the 2021 Congress of the Schizophrenia International Research Society (SIRS), taking place virtually April 17-21, 2021.
The company s presentations included new exploratory analyses from the phase 3 ENLIGHTEN-2 study of olanzapine/samidorphan (LYBALVI™), formerly referred to as ALKS 3831, including:
Results from prespecified subgroup analyses evaluating olanzapine/samidorphan s effect on weight gain across several patient subgroups, including those known to be at higher risk for weight gain with olanzapine, based ....

United States , Craig Hopkinson , Marisa Borgasano , Aripiprazole Lauroxil , Sandy Coombs , Exchange Commission , Schizophrenia International Research Society , Alkermes Pharma Ireland , Research Development , Executive Vice President , Chief Medical Officer , Patients Known , Increased Risk , Weight Gain With Olanzapine Treatment , With Olanzapine , Results From , Week Phase , Long Term Safety , Samidorphan Combination , Patients With Schizophrenia , Pooled Analyses From Phase , Long Term Weight , Metabolic Effects , Long Term Antipsychotic Efficacy , Vivo Characterization , Opioid Receptor Binding Profiles ,

Baudax Bio Strengthens Management Team with Appointment of Richard S. Casten as Chief Financial Officer

Baudax Bio Strengthens Management Team with Appointment of Richard S. Casten as Chief Financial Officer
Company Also Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
March 08, 2021 07:00 ET
| Source:
Baudax Bio, Inc.
Baudax Bio, Inc.
Malvern, Pennsylvania, UNITED STATES
MALVERN Pa., March 08, 2021 (GLOBE NEWSWIRE) Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced the appointment of Richard S. Casten, CPA, MBA as Chief Financial Officer. In this role, Mr. Casten will be responsible for leading and directing the financial activities of the Company. Mr. Casten brings to Baudax 25 years of diversified financial experience across pharmaceutical, Fortune 500 consumer products and public accounting. He replaces Ryan D. Lake, CPA who is transitioning to full time Chief Financial Officer for Recro. ....

Lehigh University , United States , Johnson School , David Rosen , Sam Martin Claudia Styslinger , Baudax Bio , Richards Casten , Gerri Henwood , Fishbein Company , Lupin Pharmaceuticals Inc , Johnson School At Cornell University , Alkermes Pharma Ireland Limited , Master In Business Administration , Baudax Bio Inc , Exchange Commission , Pennsylvania Institute Of Certified Public Accountants , Ernst Young , Endo International , Advisory Business Services , Campbell Soup Company , Chief Financial , Chief Financial Officer , Chief Executive Officer , Vice President , Lupin Pharmaceuticals , Senior Director ,